NMDA receptor antagonists (Pierre Fabre)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNMDA receptor antagonists (Pierre Fabre)
Drug Alias NameN-methyl-D-aspartate antagonists (Pierre Fabre)F-17475
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Ltd
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A